Evolus Gross Margin 2016-2025 | EOLS
Current and historical gross margin for Evolus (EOLS) over the last 10 years. The current gross profit margin for Evolus as of June 30, 2025 is %.
| Evolus Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-06-30 | $0.28B | $0.19B | 67.27% |
| 2025-03-31 | $0.28B | $0.19B | 68.48% |
| 2024-12-31 | $0.27B | $0.18B | 68.80% |
| 2024-09-30 | $0.25B | $0.17B | 68.55% |
| 2024-06-30 | $0.24B | $0.16B | 68.35% |
| 2024-03-31 | $0.22B | $0.15B | 68.49% |
| 2023-12-31 | $0.20B | $0.14B | 68.81% |
| 2023-09-30 | $0.19B | $0.13B | 68.65% |
| 2023-06-30 | $0.17B | $0.11B | 66.27% |
| 2023-03-31 | $0.16B | $0.10B | 62.42% |
| 2022-12-31 | $0.15B | $0.09B | 59.73% |
| 2022-09-30 | $0.14B | $0.08B | 57.86% |
| 2022-06-30 | $0.13B | $0.08B | 57.14% |
| 2022-03-31 | $0.12B | $0.07B | 57.38% |
| 2021-12-31 | $0.10B | $0.06B | 56.00% |
| 2021-09-30 | $0.09B | $0.05B | 58.14% |
| 2021-06-30 | $0.08B | $0.05B | 62.34% |
| 2021-03-31 | $0.06B | $0.04B | 66.10% |
| 2020-12-31 | $0.06B | $0.04B | 66.67% |
| 2020-09-30 | $0.06B | $0.04B | 74.55% |
| 2020-06-30 | $0.05B | $0.04B | 74.00% |
| 2020-03-31 | $0.04B | $0.03B | 75.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.486B | $0.266B |
| Evolus, Inc. is a medical aesthetics company. It focuses on providing physicians and patients in aesthetic procedures and treatments. The company focuses on the self-pay aesthetic market and its lead product candidate, DWP-450, is an injectable 900 kDa purified botulinum toxin type A complex. Evolus, Inc. is based in Irvine, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $228.644B | 26.81 |
| Boston Scientific (BSX) | United States | $156.695B | 37.37 |
| Stryker (SYK) | United States | $148.974B | 30.33 |
| EssilorLuxottica (ESLOY) | France | $142.491B | 0.00 |
| Medtronic (MDT) | Ireland | $117.956B | 16.63 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.926B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.457B | 24.85 |
| ResMed (RMD) | United States | $40.320B | 28.84 |
| Agilent Technologies (A) | United States | $35.497B | 22.93 |
| GE HealthCare Technologies (GEHC) | United States | $33.658B | 15.82 |
| Terumo (TRUMY) | Japan | $26.798B | 31.75 |
| Koninklijke Philips (PHG) | Netherlands | $26.557B | 17.57 |
| Insulet (PODD) | United States | $23.765B | 79.62 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.812B | 13.25 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.306B | 0.00 |
| Baxter (BAX) | United States | $12.532B | 9.68 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.947B | 29.19 |
| Lantheus Holdings (LNTH) | United States | $3.774B | 10.20 |
| Envista Holdings (NVST) | United States | $3.531B | 24.71 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.310B | 14.69 |
| Perrigo (PRGO) | Ireland | $3.269B | 8.16 |
| ICU Medical (ICUI) | United States | $3.136B | 21.35 |
| Haemonetics (HAE) | United States | $2.618B | 11.69 |
| Curaleaf Holdings (CURLF) | Canada | $2.259B | 0.00 |
| Acuren (TIC) | United States | $2.215B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $2.157B | 46.25 |
| QuidelOrtho (QDEL) | United States | $1.901B | 11.97 |
| Green Thumb Industries (GTBIF) | United States | $1.865B | 80.09 |
| AtriCure (ATRC) | United States | $1.850B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.618B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.559B | 18.40 |
| AdaptHealth (AHCO) | United States | $1.250B | 17.77 |
| Neogen (NEOG) | United States | $1.249B | 19.83 |
| BioLife Solutions (BLFS) | United States | $1.194B | 2492.00 |
| InMode (INMD) | Israel | $0.943B | 8.73 |
| Kestra Medical Technologies (KMTS) | United States | $0.909B | 0.00 |
| Valneva SE (VALN) | France | $0.752B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.727B | 0.00 |
| SNDL (SNDL) | Canada | $0.707B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.608B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.597B | 0.00 |
| ZimVie (ZIMV) | United States | $0.533B | 20.54 |
| Surmodics (SRDX) | United States | $0.491B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.476B | 16.39 |
| Canopy Growth (CGC) | Canada | $0.451B | 0.00 |
| CeriBell (CBLL) | United States | $0.439B | 0.00 |
| Owens & Minor (OMI) | United States | $0.383B | 3.40 |
| Sanuwave Health (SNWV) | United States | $0.364B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.343B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.317B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.300B | 0.00 |
| Brainsway (BWAY) | Israel | $0.290B | 59.00 |
| High Tide (HITI) | Canada | $0.290B | 0.00 |
| Omeros (OMER) | United States | $0.288B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.286B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.280B | 21.26 |
| TriSalus Life Sciences (TLSI) | United States | $0.255B | 0.00 |
| Cerus (CERS) | United States | $0.251B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.241B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.238B | 0.00 |
| Organigram Global (OGI) | Canada | $0.232B | 0.00 |
| Exagen (XGN) | United States | $0.214B | 0.00 |
| Quanterix (QTRX) | United States | $0.211B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.199B | 16.59 |
| FitLife Brands (FTLF) | United States | $0.175B | 21.60 |
| Biote (BTMD) | United States | $0.172B | 5.69 |
| Jushi Holdings (JUSHF) | United States | $0.147B | 0.00 |
| Jin Medical (ZJYL) | China | $0.124B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.114B | 0.00 |
| MacroGenics (MGNX) | United States | $0.107B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.70 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| Apyx Medical (APYX) | United States | $0.076B | 0.00 |
| Agape ATP (ATPC) | $0.067B | 0.00 | |
| Rockwell Medical (RMTI) | United States | $0.062B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.059B | 0.00 |
| Safety Shot (SHOT) | United States | $0.058B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 32.21 |
| MariMed (MRMD) | United States | $0.054B | 0.00 |
| Zynex (ZYXI) | United States | $0.050B | 0.00 |
| Veru (VERU) | United States | $0.049B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 33.58 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.34 |
| Senestech (SNES) | United States | $0.024B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Sharps Technology (STSS) | United States | $0.016B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |